Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3. This appears to be an administrative update to the page with no changes to study data.
    Difference
    0.0%
    Check dated 2026-03-11T17:32:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site; removed the government funding lapse notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T10:56:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:25:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include a glossary display, new QC-related metadata labels, and a revision bump to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:19:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. No substantive study content was changed.
    Difference
    0.0%
    Check dated 2026-01-14T03:02:22.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing state-level sites (Arizona, Arkansas, California, Colorado, Illinois, Kansas, Kentucky, Minnesota, Nebraska, New York, Ohio, Oregon, Texas, Virginia, Washington) and updated metadata to Last Update Posted (Estimated) and Revision: v3.3.3. The old per-state location headers and prior revision indicator were removed.
    Difference
    1%
    Check dated 2025-12-23T12:42:07.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.